Latest filing published 03 Dec 2020 for Acorda Therapeutics INC, €618.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
David Lawrence: trading record in brief
All filings by David Lawrence on record concern Acorda Therapeutics Inc. Over a trading history stretching from 6 November 2006 to 1 December 2020, the count stands at 354 filings.
On the market, this insider has only sold: 312 sales, €9.4M in total. The rest of the record consists of 19 share grants and 23 option exercises.
The latest filing, published on 3 December 2020, reports a share grant of €618 in Acorda Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David Lawrence
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,141 shares@ US$0.646445.5% of flowCommon StockSEC:0001209191-20-061355:0
- 1,024 shares@ US$0.859954.5% of flowCommon StockSEC:0001209191-20-057819:0
- 3,015 shares0Common StockSEC:0001209191-20-051240:0
- 1,176 shares@ US$1.602.4% of flowCommon StockSEC:0001209191-19-058937:0
- 9,045 shares0Common StockSEC:0001209191-19-018794:0
- 761 shares@ US$13.180.4% of flowCommon StockSEC:0001209191-19-012973:0
- 2,200 shares0Common StockSEC:0001209191-18-064142:0
- 2,493 shares@ US$20.551.9% of flowCommon StockSEC:0001209191-18-061106:0
- 747 shares@ US$20.280.5% of flowCommon StockSEC:0001209191-18-057557:0
- 2,200 shares0Common StockSEC:0001209191-18-050633:0
- 3,131 shares@ US$31.651.6% of flowCommon StockSEC:0001209191-18-037359:0
- 300 shares@ US$32.680.2% of flowCommon StockSEC:0001209191-18-037359:1
- 19,880 shares@ US$20.596.6% of flowCommon StockSEC:0001209191-18-036828:0
- 19,880 shares@ US$28.029.0% of flowCommon StockSEC:0001209191-18-036828:1
- 5,120 shares@ US$20.591.7% of flowCommon StockSEC:0001209191-18-036828:2
- 4,000 shares@ US$28.411.8% of flowCommon StockSEC:0001209191-18-036828:3
- 400 shares@ US$29.610.2% of flowCommon StockSEC:0001209191-18-036828:4
- 500 shares@ US$30.580.2% of flowCommon StockSEC:0001209191-18-036828:5
- 200 shares@ US$31.900.1% of flowCommon StockSEC:0001209191-18-036828:6
- 20 shares@ US$33.100.0% of flowCommon StockSEC:0001209191-18-036828:7
- 1,766 shares@ US$25.650.7% of flowCommon StockSEC:0001209191-18-018699:0
- 5,197 shares0Common StockSEC:0001209191-18-013212:0
- 582 shares@ US$19.810.2% of flowCommon StockSEC:0001209191-18-004680:0
- 582 shares@ US$27.000.2% of flowCommon StockSEC:0001209191-18-004680:1
- 30,418 shares@ US$19.819.4% of flowCommon StockSEC:0001209191-18-004680:2
25 of 341 declarations
